3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Neutropenia
1
Neoplasms
1
Hematologic Neoplasms
1
Fever
1
Febrile Neutropenia
1
Interventions
Filgrastim
9
Cytarabine
7
Etoposide
5
Cefepime
4
Peripheral Blood Stem Cell Transplantation
3
Mitoxantrone
3
Levofloxacin
3
Idarubicin
3
Daunorubicin
3
Cyclosporine
3
Ciprofloxacin
3
Caspofungin
3
pegfilgrastim
2
liposomal amphotericin B
2
Thioguanine
2
Radiotherapy
2
Methotrexate
2
Meropenem
2
Itraconazole
2
Cyclophosphamide
2
Ceftazidime
2
Amsacrine
2
Amoxicillin-Potassium Clavulanate Combination
2
sargramostim
1
posaconazole
1
lintuzumab
1
leridistim
1
isavuconazole
1
fludarabine phosphate
1
flt3 ligand protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neutropenia
×
Cilastatin, Imipenem Drug Combination
×
Other hematologic neoplasm
×
Clear all
NCT02149329
2019-09-25
SHORT
Amsterdam UMC, location VUmc
Phase 4
Completed
276 enrolled